Phreesia (NYSE:PHR) Trading Up 5.6%

Phreesia, Inc. (NYSE:PHR - Get Free Report)'s stock price shot up 5.6% on Monday . The stock traded as high as $23.03 and last traded at $23.02. 232,153 shares traded hands during trading, a decline of 56% from the average session volume of 524,243 shares. The stock had previously closed at $21.79.

Wall Street Analyst Weigh In

Several research firms recently weighed in on PHR. Truist Financial began coverage on Phreesia in a report on Monday, February 26th. They set a "buy" rating and a $35.00 price target on the stock. DA Davidson restated a "neutral" rating and set a $32.00 price target on shares of Phreesia in a report on Friday, March 15th. Robert W. Baird increased their target price on Phreesia from $30.00 to $31.00 and gave the stock an "outperform" rating in a research note on Monday, March 18th. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 target price on shares of Phreesia in a research note on Friday, March 15th. Finally, Barclays initiated coverage on Phreesia in a research note on Wednesday, January 3rd. They issued an "overweight" rating and a $29.00 target price on the stock. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, Phreesia has an average rating of "Moderate Buy" and a consensus price target of $31.62.

Phreesia Stock Performance

The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.78 and a current ratio of 1.78. The firm has a 50 day moving average price of $24.96 and a 200 day moving average price of $20.98.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) EPS for the quarter, beating the consensus estimate of ($0.58) by $0.02. The firm had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The business's revenue for the quarter was up 24.0% on a year-over-year basis. During the same quarter last year, the firm posted ($0.72) earnings per share. Sell-side analysts predict that Phreesia, Inc. will post -1.46 earnings per share for the current year.

Insider Activity at Phreesia

In related news, General Counsel Allison C. Hoffman sold 1,316 shares of the firm's stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $24.55, for a total transaction of $32,307.80. Following the sale, the general counsel now owns 144,464 shares of the company's stock, valued at $3,546,591.20. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, General Counsel Allison C. Hoffman sold 1,316 shares of the firm's stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $24.55, for a total transaction of $32,307.80. Following the sale, the general counsel now owns 144,464 shares of the company's stock, valued at $3,546,591.20. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Evan Roberts sold 2,247 shares of the firm's stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $24.55, for a total value of $55,163.85. Following the sale, the chief operating officer now directly owns 795,613 shares in the company, valued at approximately $19,532,299.15. The disclosure for this sale can be found here. Insiders have sold a total of 39,344 shares of company stock valued at $936,390 over the last quarter. 5.80% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Phreesia

Institutional investors have recently added to or reduced their stakes in the business. CI Investments Inc. boosted its holdings in Phreesia by 6.6% in the third quarter. CI Investments Inc. now owns 477,265 shares of the company's stock worth $8,915,000 after acquiring an additional 29,500 shares in the last quarter. Schroder Investment Management Group acquired a new stake in shares of Phreesia during the third quarter worth about $6,514,000. TimesSquare Capital Management LLC lifted its holdings in shares of Phreesia by 7.8% during the third quarter. TimesSquare Capital Management LLC now owns 774,079 shares of the company's stock worth $14,460,000 after purchasing an additional 55,793 shares during the period. Lazard Asset Management LLC lifted its holdings in shares of Phreesia by 58.6% during the third quarter. Lazard Asset Management LLC now owns 424,047 shares of the company's stock worth $7,921,000 after purchasing an additional 156,711 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Phreesia by 5.1% during the third quarter. Bank of New York Mellon Corp now owns 195,275 shares of the company's stock worth $3,648,000 after purchasing an additional 9,501 shares during the period. Institutional investors and hedge funds own 92.10% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.